Matrix metalloproteinase 2 activation in cultured corneas

V A Smith1, A El-Rakhawy, D L Easty

  • 1Division of Ophthalmology, Bristol Eye Hospital, University of Bristol, UK.

Ophthalmic Research
|December 15, 2000
PubMed
Abstract

Insights

Activated matrix metalloproteinase-2 (MMP-2) is produced in cultured corneas, potentially damaging the epithelial basement membrane. Corneal grafts stored longer than 4 weeks may have impaired healing due to this MMP-2 activation.

Area of Science:

  • Ophthalmology
  • Biochemistry
  • Tissue Engineering

Background:

  • Corneal epithelial cell shedding and poor repopulation after transplantation can result from damage to the epithelial basement membrane.
  • Matrix metalloproteinase-2 (MMP-2), produced by corneal keratocytes, is investigated for its role in this damage.

Purpose of the Study:

  • To determine if MMP-2 activation occurs during corneal storage in culture medium.
  • To investigate if activated MMP-2 cleaves type IV collagen in the epithelial basement membrane.

Main Methods:

  • Analysis of fresh and rejected corneas stored for various durations.
  • Soluble protein extraction and MMP-2 visualization via zymography.
  • Assay of MMP-2 activity against collagen and other substrates.

Main Results:

  • Fresh corneas contained inactive MMP-2 (66,000 M(r)).
  • Cultured corneas showed additional active MMP-2 forms (62,000 and 43,000 M(r)) that correlated with storage time.
  • The 43,000 M(r) MMP-2 form correlated with collagen cleavage activity.

Conclusions:

  • Activated MMP-2 is generated in corneas during culture.
  • Corneal storage in culture medium should not exceed 4 weeks to preserve graft integrity.